Correlation Between NewAmsterdam Pharma and Bioatla

Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NewAmsterdam Pharma and Bioatla, you can compare the effects of market volatilities on NewAmsterdam Pharma and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Bioatla.

Diversification Opportunities for NewAmsterdam Pharma and Bioatla

0.18

Correlation Coefficient

NewAmsterdam Pharma  Bioatla

Average diversification

The 3 months correlation between NewAmsterdam and Bioatla is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Bioatla go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Bioatla

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 0.56 times more return on investment than Bioatla. However, NewAmsterdam Pharma is 1.79 times less risky than Bioatla. It trades about 0.03 of its potential returns per unit of risk. Bioatla is currently generating about -0.2 per unit of risk. If you would invest  2,136  in NewAmsterdam Pharma on December 4, 2024 and sell it today you would earn a total of  14.00  from holding NewAmsterdam Pharma or generate 0.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NewAmsterdam Pharma  vs.  Bioatla

NewAmsterdam Pharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, NewAmsterdam Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bioatla

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with NewAmsterdam Pharma and Bioatla

The main advantage of trading using opposite NewAmsterdam Pharma and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.

The idea behind NewAmsterdam Pharma and Bioatla pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.